“Pfizer Shot Remains More Than 91% Effective After Six Months”
Pfizer Inc.’s Covid-19 vaccine remained highly effective after six months, according to new long-term results that the company said could be used to seek an expansion of its regulatory status.
Follow-up data from a final-stage trial of 46,307 people showed the vaccine was 91.3% effective in preventing symptomatic cases starting one week after the second dose through as long as six months. In the U.S. alone, the efficacy rate was 92.6%, according to a report Thursday by Pfizer and its partner BioNTech SE.
At the same time, the companies provided some of the first data on how their vaccine might handle the immune-evading B.1.351 variant that arose in South Africa. Nine of 800 trial participants in that country got sick with Covid, including six infected with B.1.351. However, all were in the placebo group, suggesting the shot retains efficacy against the variant.
Albert Bourla, Pfizer’s Chief Executive Officer, said in the statement that the results “position us to submit a Biologics License Application to the U.S. FDA.”
46k follow-ups are still a small specimen to make such conclusions. But the end of this is for seeking full FDA approval for profits as a product going forward and to make this product as well as its derivatives (needle-less administration) for the future more viable. It is all business. But the mark of the beast will find its way to more human beings to mark them.
On the spiritual part of the commentary in reviewing this news release, we are not talking about the technical side of the mRNA, it is saying in effect that the mRNA is still working inside the patient’s body by making through giving genetic instructions, for the cells to be self-making the S-protein of the coronavirus and release it internally to the patient’s body as well as spread the virus to others around them (THAT’S WHY they MUST wear a mask AFTER the vaccination as a spreader).
Understanding mRNA COVID-19 Vaccines
Updated Mar. 4, 2021LanguagesPrint
Messenger RNA vaccines—also called mRNA vaccines—are some of the first COVID-19 vaccines authorized for use in the United States.
New Approach to Vaccines
mRNA vaccines are a new type of vaccine to protect against infectious diseases. To trigger an immune response, many vaccines put a weakened or inactivated germ into our bodies. Not mRNA vaccines. Instead, they teach our cells how to make a protein—or even just a piece of a protein—that triggers an immune response inside our bodies. That immune response, which produces antibodies, is what protects us from getting infected if the real virus enters our bodies.
A Closer Look at How COVID-19 mRNA Vaccines Work
COVID-19 mRNA vaccines give instructions for our cells to make a harmless piece of what is called the “spike protein.” The spike protein is found on the surface of the virus that causes COVID-19.
COVID-19 mRNA vaccines are given in the upper arm muscle. Once the instructions (mRNA) are inside the immune cells, the cells use them to make the protein piece. After the protein piece is made, the cell breaks down the instructions and gets rid of them.
Next, the cell displays the protein piece on its surface. Our immune systems recognize that the protein doesn’t belong there and begin building an immune response and making antibodies, like what happens in natural infection against COVID-19.
At the end of the process, our bodies have learned how to protect against future infection. The benefit of mRNA vaccines, like all vaccines, is those vaccinated gain this protection without ever having to risk the serious consequences of getting sick with COVID-19. End quote.
Watch the language very carefully: ” those vaccinated gain this protection without ever having to risk the serious consequences of getting sick with COVID-19″. Define sick. In fact, we already know that thousands who received the mRNA have gotten sick and even died. So that statement is untrue. Their hope, as I understand it, means the goal is not to get morbidly sick, just “OK” sick as the patient deals with the mild infection of the new S proteins inside their bodies now, viewed internally as foreign cells and thus rejection begins by producing immune response.
Antibodies attach to a specific antigen and make it easier for the immune cells to destroy the antigen. T lymphocytes attack antigens directly and help control the immune response. They also release chemicals, known as cytokines, which control the entire immune response. Source: https://medlineplus.gov/ency/article/000821.htm
Since the mRNA has one job, to work with the person’s DNA to make novel proteins, the person will be continuing to make these proteins which will affect the other areas of their biology. The CDC publication mentions that the mRNA instructions will be broken down, but it only refers to the cells that interacted with existing body cells.
It makes my point of transhumanism. No redemption by the Coming Son of Man for the non-humans.